In Texas, Compound Laws tracks 19 compounds: 3 legal to sell at retail, 7 restricted, 0 in a gray area, 4 illegal, and 5 whose status varies by product form. Verified through October 22, 2026.
70469b3f81bc9e09AGRICULTURE CODE, TITLE 5, SUBTITLE F. HEMP, CHAPTER 121. STATE HEMP PRODUCTION PLAN Sec. 121.001. DEFINITION. In this chapter, "hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds of the plant and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis. Added by Acts 2019, 86th Leg., R.S., Ch. 764 (H.B. 1325), Sec. 2, eff. June 10, 2019. Sec. 121.002. LEGISLATIVE INTENT. It is the intent of the legislature that this state have primary regulatory authority over the production of hemp in this state. Added by Acts 2019, 86th Leg., R.S., Ch. 764 (H.B. 1325), Sec. 2, eff. June 10, 2019. Sec. 121.003. STATE PLAN. (a) The department, after consulting with the governor and attorney general, shall develop a state plan to monitor and regulate the production of hemp in this state. The plan must comply with: (1) 7 U.S.C. Section 1639p; (2) Chapter 122; and (3) Chapter 443, Health and Safety Code. (b) The department shall submit the plan developed under Subsection (a) to the secretary of the United States Department of Agriculture as this state's plan for monitoring and regulating the production of hemp as provided by 7 U.S.C. Section 1639p. (c) If a plan submitted under Subsection (b) is disapproved by the secretary of the United States Department of Agriculture, the department, after consulting with the governor and attorney general, shall amend the plan as needed to obtain approval and submit an amended plan. (d) The department shall, as necessary, seek technical assistance from the secretary of the United States Department of Agriculture and other state agencies in developing the plan under this section. Added by Acts 2019, 86th Leg., R.S., Ch. 764 (H.B. 1325), Sec. 2, eff. June 10, 2019. Sec. 121.004. RULES. The department may adopt any rules necessary to implement and administer the state plan under Section 121.003. Added by Acts 2019, 86th Leg., R.S., Ch. 764 (H.B. 1325), Sec. 2, eff. June 10, 2019.
0aec322dd401fb2c**§ 481.103(a)(5) (Penalty Group 2 tryptamine structural class)** — "(5) any compound structurally derived from tryptamine (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine: (A) by modification in any of the following ways: (i) by substitution at the amine nitrogen atom of the sidechain to any extent with alkyl or alkenyl groups or by inclusion of the amine nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure; (ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain (alpha-position) with an alkyl or alkenyl group; (iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl, alkylenedioxy, or halide substituents; or (iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent; and (B) including: (i) ethers and esters of the controlled substances listed in this subdivision; and (ii) by example, compounds such as: alpha-ethyltryptamine; alpha-methyltryptamine; Bufotenine …; Diethyltryptamine …; Dimethyltryptamine (DMT); 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DiPT); O-Acetylpsilocin (Trade or other name: 4-Aco-DMT); Psilocin; and Psilocybin;" — Tex. Health & Safety Code § 481.103(a)(5), https://law.justia.com/codes/texas/2021/health-and-safety-code/title-6/subtitle-c/chapter-481/subchapter-d/section-481-103/ (MIRROR: Justia, 2021; the (a)(5) class text is unchanged in the current code).
9bf4bb0d44fb80d5SECTION 2. Section 161.0876, Health and Safety Code, is amended to read as follows: Sec. 161.0876. PROHIBITED E-CIGARETTE PRODUCTS. (a) For purposes of this section, "e-cigarette product" means a consumable liquid solution or other material aerosolized or vaporized during the use of an electronic cigarette or other device described by Section 161.081(1-a), regardless of whether the liquid solution or material contains nicotine. The term does not include a prescription medication or other prescribed substance unrelated to the cessation of smoking [ includes any substance containing nicotine from any source that is intended for use in an e-cigarette ]. (b) A person commits an offense if the person markets, advertises, sells, offers for sale, or causes to be sold an e-cigarette product : (1) in a product [ , if the product's ] container that : (A) [ (1) ] depicts a cartoon-like fictional character that mimics a character primarily aimed at entertaining minors; (B) [ (2) ] imitates or mimics trademarks or trade dress of products that are or have been primarily marketed to minors; (C) [ (3) ] includes a symbol that is primarily used to market products to minors; (D) [ (4) ] includes an image or name of a celebrity; or (E) [ (5) ] includes an image that resembles a food product, including candy or juice ; (2) in a product shape or design disguised to appear as an alternative product, including a product in the shape or design of: (A) a school or office supply, such as a highlighter, marker, ink pen, or pencil; (B) a smart phone, smart watch, smart phone case, or smart watch case; (C) headphones, including ear buds; (D) clothing; (E) a backpack; (F) a cosmetic, including lipstick; or (G) a toy; (3) that is wholly or partially manufactured in or marketed as being manufactured in: (A) China; or (B) a country designated as a foreign adversary by the United States secretary of commerce under 15 C.F.R. Section 791.4; or (4) that contains, is mixed with, or is marketed as containing or being mixed with any cannabinoids, alcohol, kratom, kava, mushrooms, tianeptine, or any derivatives of those substances . (c) An offense under this section is a Class A [ B ] misdemeanor.
b312d934e76a2043Sec. 443.204. RULES RELATED TO SALE OF CONSUMABLE HEMP PRODUCTS. Rules adopted by the executive commissioner regulating the sale of consumable hemp products must to the extent allowable by federal law reflect the following principles: (1) hemp-derived cannabinoids, including cannabidiol, are not considered controlled substances or adulterants; (2) products containing one or more hemp-derived cannabinoids, such as cannabidiol, intended for ingestion are considered foods, not controlled substances or adulterated products; (3) consumable hemp products must be packaged and labeled in the manner provided by Section 443.205 ; and (4) the processing or manufacturing of a consumable hemp product for smoking is prohibited. Added by Acts 2019, 86th Leg., R.S., Ch. 764 (H.B. 1325 ), Sec. 7, eff. June 10, 2019. §300.701. Restriction on Sale to Minors. (a) A person is prohibited from delivering, selling, or offering to sell a consumable hemp product to a minor. (b) A person who sells CHP must verify each purchaser's age by reviewing a valid proof of identification before completing the sale of any CHP. (c) A valid proof of identification may include a driver's license issued by Texas or another state, a passport, or an identification card issued by a state or government agency. A valid proof of identification must meet the following criteria: (1) include a physical description and a photograph that matches the person's appearance; (2) provide the individual's date of birth; (3) be issued by a government agency; and (4) is not expired.
b1ab24f65eea30deSec. 443.204. RULES RELATED TO SALE OF CONSUMABLE HEMP PRODUCTS. "Rules adopted by the executive commissioner regulating the sale of consumable hemp products must" "to the extent allowable by federal law reflect the following principles:" (1) "hemp-derived cannabinoids, including cannabidiol, are not considered controlled substances or adulterants;" (2) "products containing one or more hemp-derived cannabinoids, such as cannabidiol, intended for ingestion" "are considered foods, not controlled substances or adulterated products;" (3) "consumable hemp products must be packaged and labeled in the manner provided by Section 443.205"; and (4) "the processing or manufacturing of a consumable hemp product for smoking is prohibited." "Added by Acts 2019, 86th Leg., R.S., Ch. 764 (H.B. 1325), Sec. 7, eff. June 10, 2019." [Text via texas.public.law fallback; official statutes.capitol.texas.gov is script-rendered.]
9c464f2a396e30b2Sec. 481.103. PENALTY GROUP 2. (a) Penalty Group 2 consists of: (1) any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, if the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 5-(2-aminopropyl)benzofuran (5-APB); 6-(2-aminopropyl)benzofuran (6-APB); 5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-APDB); 6-(2-aminopropyl)-2,3-dihydrobenzofuran (6-APDB); 5-(2-aminopropyl)indole (5-IT,5-API); 6-(2-aminopropyl)indole (6-IT,6-API); 1-(benzofuran-5-yl)-N-methylpropan-2-amine (5-MAPB); 1-(benzofuran-6-yl)-N-methylpropan-2-amine (6-MAPB); Benzothiophenylcyclohexylpiperidine (BTCP); 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran- 4-ethanamine (trade or other name: Bromo-DragonFLY); Desoxypipradrol (2-benzhydrylpiperidine); 2, 5-dimethoxyamphetamine (some trade or other names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); Diphenylprolinol (diphenyl(pyrrolidin-2-yl) methanol, D2PM); Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product (some trade or other names for Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- (trans)- tetrahydrocannabinol); Ethylamine Analog of Phencyclidine (some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1- phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE); 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone (trade or other name: methoxetamine); Ibogaine (some trade or other names: 7-Ethyl-6, 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); 5-iodo-2-aminoindane (5-IAI); Mescaline; 5-methoxy-3, 4-methylenedioxy amphetamine; 4-methoxyamphetamine (some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA); 4-methoxymethamphetamine (PMMA); 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone (some trade and other names: 2-MeO-ketamine; methoxyketamine); 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, PPMP); 4-methyl-2, 5-dimethoxyamphetamine (some trade and other names: 4-methyl-2, 5-dimethoxy-alpha- methylphenethylamine; "DOM"; "STP"); 3,4-methylenedioxy methamphetamine (MDMA, MDM); 3,4-methylenedioxy amphetamine; 3,4-methylenedioxy N-ethylamphetamine (Also known as N-ethyl MDA); 5,6-methylenedioxy-2-aminoindane (MDAI); Nabilone (Another name for nabilone: (+)-trans- 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, 6-dimethyl-9H-dibenzo[b,d] pyran-9-one; N-benzylpiperazine (some trade or other names: BZP; 1-benzylpiperazine); N-ethyl-3-piperidyl benzilate; N-hydroxy-3,4-methylenedioxyamphetamine (Also known as N-hydroxy MDA); 4-methylaminorex; N-methyl-3-piperidyl benzilate; Parahexyl (some trade or other names: 3-Hexyl-1- hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] pyran; Synhexyl); 1-Phenylcyclohexylamine; 1-Piperidinocyclohexanecarbonitrile (PCC); Pyrrolidine Analog of Phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); Tetrahydrocannabinols, other than marihuana, and synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as: delta-1 cis or trans tetrahydrocannabinol, and their optical isomers; delta-6 cis or trans tetrahydrocannabinol, and their optical isomers; delta-3, 4 cis or trans tetrahydrocannabinol, and its optical isomers; or compounds of these structures, regardless of numerical designation of atomic positions, since nomenclature of these substances is not internationally standardized; Thiophene Analog of Phencyclidine (some trade or other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl Analog of Phencyclidine; TPCP, TCP); 1-pyrrolidine (some trade or other name: TCPy); 1-(3-trifluoromethylphenyl)piperazine (trade or other name: TFMPP); and 3,4,5-trimethoxy amphetamine; (2) Phenylacetone (some trade or other names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl ketone); (3) unless specifically excepted or unless listed in another Penalty Group, a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant or stimulant effect on the central nervous system: Aminorex (some trade or other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- phenyl-2-oxazolamine); Amphetamine, its salts, optical isomers, and salts of optical isomers; Cathinone (some trade or other names: 2-amino-1- phenyl-1-propanone, alpha-aminopropiophenone, 2- aminopropiophenone); Etaqualone and its salts; Etorphine Hydrochloride; Fenethylline and its salts; Lisdexamfetamine, including its salts, isomers, and salts of isomers; Mecloqualone and its salts; Methaqualone and its salts; Methcathinone (some trade or other names: 2- methylamino-propiophenone; alpha-(methylamino)propriophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N- methylaminopropriophenone; monomethylpropion; ephedrone, N- methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR 1431); N-Ethylamphetamine, its salts, optical isomers, and salts of optical isomers; and N,N-dimethylamphetamine (some trade or other names: N,N,alpha-trimethylbenzeneethanamine; N,N,alpha-trimethylphenethylamine), its salts, optical isomers, and salts of optical isomers; (4) any compound structurally derived from 2-aminopropanal by substitution at the 1-position with any monocyclic or fused-polycyclic ring system, including: (A) compounds further modified by: (i) substitution in the ring system to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), whether or not further substituted in the ring system by other substituents; (ii) substitution at the 3-position with an alkyl substituent; or (iii) substitution at the 2-amino nitrogen atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or inclusion of the 2-amino nitrogen atom in a cyclic structure; and (B) by example, compounds such as: 4-Methylmethcathinone (Also known as Mephedrone); 3,4-Dimethylmethcathinone (Also known as 3,4-DMMC); 3-Fluoromethcathinone (Also known as 3-FMC); 4-Fluoromethcathinone (Also known as Flephedrone); 3,4-Methylenedioxy-N-methylcathinone (Also known as Methylone); 3,4-Methylenedioxypyrovalerone (Also known as MDPV); alpha-Pyrrolidinopentiophenone (Also known as alpha-PVP); Naphthylpyrovalerone (Also known as Naphyrone); alpha-Methylamino-valerophenone (Also known as Pentedrone); beta-Keto-N-methylbenzodioxolylpropylamine (Also known as Butylone); beta-Keto-N-methylbenzodioxolylpentanamine (Also known as Pentylone); beta-Keto-Ethylbenzodioxolylbutanamine (Also known as Eutylone); and 3,4-methylenedioxy-N-ethylcathinone (Also known as Ethylone); (5) any compound structurally derived from tryptamine (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine: (A) by modification in any of the following ways: (i) by substitution at the amine nitrogen atom of the sidechain to any extent with alkyl or alkenyl groups or by inclusion of the amine nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure; (ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain (alpha-position) with an alkyl or alkenyl group; (iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl, alkylenedioxy, or halide substituents; or (iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent; and (B) including: (i) ethers and esters of the controlled substances listed in this subdivision; and (ii) by example, compounds such as: alpha-ethyltryptamine; alpha-methyltryptamine; Bufotenine (some trade and other names: 3-(beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin; 5-hydroxy-N, N- dimethyltryptamine; mappine); Diethyltryptamine (some trade and other names: N, N-Diethyltryptamine, DET); Dimethyltryptamine (trade or other name: DMT); 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DiPT); O-Acetylpsilocin (Trade or other name: 4-Aco-DMT); Psilocin; and Psilocybin; (6) 2,5-Dimethoxyphenethylamine and any compound structurally derived from 2,5-Dimethoxyphenethylamine by substitution at the 4-position of the phenyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), including, by example, compounds such as: 4-Bromo-2,5-dimethoxyphenethylamine (trade or other name: 2C-B); 4-Chloro-2,5-dimethoxyphenethylamine (trade or other name: 2C-C); 2,5-Dimethoxy-4-methylphenethylamine (trade or other name: 2C-D); 4-Ethyl-2,5-dimethoxyphenethylamine (trade or other name: 2C-E); 4-Iodo-2,5-dimethoxyphenethylamine (trade or other name: 2C-I); 2,5-Dimethoxy-4-nitrophenethylamine (trade or other name: 2C-N); 2,5-Dimethoxy-4-(n)-propylphenethylamine (trade or other name: 2C-P); 4-Ethylthio-2,5-dimethoxyphenethylamine (trade or other name: 2C-T-2); 4-Isopropylthio-2,5-dimethoxyphenethylamine (trade or other name: 2C-T-4); and 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (trade or other name: 2C-T-7); and (7) 2,5-Dimethoxyamphetamine and any compound structurally derived from 2,5-Dimethoxyamphetamine by substitution at the 4-position of the phenyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), including, by example, compounds such as: 4-Ethylthio-2,5-dimethoxyamphetamine (trade or other name: Aleph-2); 4-Isopropylthio-2,5-dimethoxyamphetamine (trade or other name: Aleph-4); 4-Bromo-2,5-dimethoxyamphetamine (trade or other name: DOB); 4-Chloro-2,5-dimethoxyamphetamine (trade or other name: DOC); 2,5-Dimethoxy-4-ethylamphetamine (trade or other name: DOET); 4-Iodo-2,5-dimethoxyamphetamine (trade or other name: DOI); 2,5-Dimethoxy-4-methylamphetamine (trade or other name: DOM); 2,5-Dimethoxy-4-nitroamphetamine (trade or other name: DON); 4-Isopropyl-2,5-dimethoxyamphetamine (trade or other name: DOIP); and 2,5-Dimethoxy-4-(n)-propylamphetamine (trade or other name: DOPR). (b) For the purposes of Subsection (a)(1) only, the term "isomer" includes an optical, position, or geometric isomer. (c) To the extent Subsection (a)(4), (5), (6), or (7) conflicts with another provision or this subtitle or another law, the other provision or the other law prevails. If a substance listed in this section is also listed in another penalty group, the listing in the other penalty group controls. (d) Repealed by Acts 2017, 85th Leg., R.S., Ch. 384 (S.B. 227 ), Sec. 1, and Ch. 491 (H.B. 2671 ), Sec. 3, eff. September 1, 2017. Amended by Acts 1997, 75th Leg., ch. 745, Sec. 23, eff. Jan. 1, 1998; Acts 2001, 77th Leg., ch. 251, Sec. 17, eff. Sept. 1, 2001; Acts 2003, 78th Leg., ch. 1099, Sec. 8, eff. Sept. 1, 2003. Amended by: Acts 2009, 81st Leg., R.S., Ch. 739 (S.B. 449 ), Sec. 2, eff. September 1, 2009. Acts 2011, 82nd Leg., R.S., Ch. 784 (H.B. 2118 ), Sec. 1, eff. September 1, 2011. Acts 2015, 84th Leg., R.S., Ch. 64 (S.B. 172 ), Sec. 3, eff. September 1, 2015. Acts 2017, 85th Leg., R.S., Ch. 384 (S.B. 227 ), Sec. 1, eff. September 1, 2017. Acts 2017, 85th Leg., R.S., Ch. 491 (H.B. 2671 ), Sec. 3, eff. September 1, 2017.
ed6166a47c68ae9e(1) any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, if the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 5-(2-aminopropyl)benzofuran (5-APB); 6-(2-aminopropyl)benzofuran (6-APB); 5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-APDB); 6-(2-aminopropyl)-2,3-dihydrobenzofuran (6-APDB); 5-(2-aminopropyl)indole (5-IT,5-API); 6-(2-aminopropyl)indole (6-IT,6-API); 1-(benzofuran-5-yl)-N-methylpropan-2-amine (5-MAPB); 1-(benzofuran-6-yl)-N-methylpropan-2-amine (6-MAPB); Benzothiophenylcyclohexylpiperidine (BTCP); 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran- 4-ethanamine (trade or other name: Bromo-DragonFLY); Desoxypipradrol (2-benzhydrylpiperidine); 2, 5-dimethoxyamphetamine (some trade or other names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); Diphenylprolinol (diphenyl(pyrrolidin-2-yl) methanol, D2PM); Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product (some trade or other names for Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- (trans)- tetrahydrocannabinol); Ethylamine Analog of Phencyclidine (some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1- phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE); 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone (trade or other name: methoxetamine); Ibogaine (some trade or other names: 7-Ethyl-6, 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); 5-iodo-2-aminoindane (5-IAI); Mescaline; 5-methoxy-3, 4-methylenedioxy amphetamine; 4-methoxyamphetamine (some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA); 4-methoxymethamphetamine (PMMA); 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone (some trade and other names: 2-MeO-ketamine; methoxyketamine); 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, PPMP); 4-methyl-2, 5-dimethoxyamphetamine (some trade and other names: 4-methyl-2, 5-dimethoxy-alpha- methylphenethylamine; "DOM"; "STP"); 3,4-methylenedioxy methamphetamine (MDMA, MDM); 3,4-methylenedioxy amphetamine; 3,4-methylenedioxy N-ethylamphetamine (Also known as N-ethyl MDA); 5,6-methylenedioxy-2-aminoindane (MDAI); Nabilone (Another name for nabilone: (+)-trans- 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, 6-dimethyl-9H-dibenzo[b,d] pyran-9-one; N-benzylpiperazine (some trade or other names: BZP; 1-benzylpiperazine); N-ethyl-3-piperidyl benzilate; N-hydroxy-3,4-methylenedioxyamphetamine (Also known as N-hydroxy MDA); 4-methylaminorex; N-methyl-3-piperidyl benzilate; Parahexyl (some trade or other names: 3-Hexyl-1- hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] pyran; Synhexyl); 1-Phenylcyclohexylamine; 1-Piperidinocyclohexanecarbonitrile (PCC); Pyrrolidine Analog of Phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); Tetrahydrocannabinols, other than marihuana, and synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as: delta-1 cis or trans tetrahydrocannabinol, and their optical isomers; delta-6 cis or trans tetrahydrocannabinol, and their optical isomers; delta-3, 4 cis or trans tetrahydrocannabinol, and its optical isomers; or compounds of these structures, regardless of numerical designation of atomic positions, since nomenclature of these substances is not internationally standardized; Thiophene Analog of Phencyclidine (some trade or other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl Analog of Phencyclidine; TPCP, TCP); 1-pyrrolidine (some trade or other name: TCPy); 1-(3-trifluoromethylphenyl)piperazine (trade or other name: TFMPP); and 3,4,5-trimethoxy amphetamine;
a60203343315cb5c(a) This section does not apply to low-THC cannabis regulated under Chapter 487. (b) Notwithstanding any other law, a person may not sell, offer for sale, possess, distribute, or transport a cannabinoid oil, including cannabidiol oil, in this state: (1) if the oil contains any material extracted or derived from the plant Cannabis sativa L., other than from hemp produced in compliance with 7 U.S.C. Chapter 38, Subchapter VII; and (2) unless a sample representing the oil has been tested by a laboratory that is accredited by an independent accreditation body in accordance with International Organization for Standardization ISO/IEC 17025 or a comparable or successor standard and found to have a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent. (c) The department and the Department of Public Safety shall establish a process for the random testing of cannabinoid oil, including cannabidiol oil, at various retail and other establishments that sell, offer for sale, distribute, or use the oil to ensure that the oil: (1) does not contain harmful ingredients; (2) is produced in compliance with 7 U.S.C. Chapter 38, Subchapter VII; and (3) has a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent.
a1ca6b1ec5b1adddSec. 445.001. DEFINITIONS. (1) "Food" has the meaning assigned by Section 431.002. (2) "Kratom" means any part of the leaf of the plant Mitragyna speciosa. (3) "Kratom processor" means a person who: (A) manufactures, prepares, distributes, or maintains kratom products for sale; (B) advertises, represents, or holds oneself out as a manufacturer, preparer, or seller of kratom products; (C) is responsible for ensuring the purity and proper labeling of kratom products; or (D) packages or labels kratom products. (4) "Kratom product" means a food, including an extract, capsule, or pill, containing any form of kratom. (5) "Kratom retailer" means a kratom processor who sells kratom products to consumers ... Sec. 445.002. LABEL REQUIRED. (a) A kratom processor shall label each kratom product with the product use directions necessary to ensure safe use ... including the recommended serving size. (b) A kratom retailer may only sell a kratom product that is properly labeled ... Sec. 445.003. ADULTERATED, CONTAMINATED, AND PROHIBITED KRATOM PRODUCTS. A kratom processor or kratom retailer may not prepare, distribute, sell, or offer to sell a kratom product that: (1) is adulterated with a dangerous non-kratom substance affecting the quality or strength of the product to a degree that renders the product injurious to a consumer; (2) is contaminated with a poisonous or otherwise deleterious non-kratom substance, including any substance designated as a controlled substance by Chapter 481 (Texas Controlled Substances Act); (3) contains a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than two percent of the overall alkaloid composition of the product; or (4) contains any synthetic alkaloids, including synthetic 7-hydroxymitragynine and synthetically derived compounds from a kratom plant. Sec. 445.004. OFFENSE FOR DISTRIBUTION OR SALE OF KRATOM PRODUCT TO MINOR. (a) A person commits an offense if the person distributes, sells, or exposes for sale a kratom product to an individual younger than 18 years of age. (b) An offense under this section is a Class C misdemeanor. Sec. 445.005 CIVIL PENALTY ($250/$500/$1,000). Sec. 445.006 penalties are in addition to Chapters 431 and 481. Sec. 445.007 rules.
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap